Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Screening and validation of plasma cell-derived, purinergic, and calcium signalling-related genetic signature to predict prognosis and PD-L1/PD-1 blockade responses in lung adenocarcinoma.
J Cancer Res Clin Oncol. 2023 Nov;149(14):12931-12945. doi: 10.1007/s00432-023-05153-8. Epub 2023 Jul 19.
J Cancer Res Clin Oncol. 2023.
PMID: 37468608
B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors.
Yang Y, Huang JF, Hu BQ, Zhou J, Wang X, Feng ZZ, Chen YT, Pan FM, Cheng HD, Chen LW.
Yang Y, et al.
World J Surg Oncol. 2022 May 20;20(1):159. doi: 10.1186/s12957-022-02634-x.
World J Surg Oncol. 2022.
PMID: 35590371
Free PMC article.
Item in Clipboard
Cite
Cite